Accumulation of microglial cells expressing ELR motif-positive CXC chemokines and their receptor CXCR2 in monkey hippocampus after ischemia-reperfusion - PubMed (original) (raw)
Accumulation of microglial cells expressing ELR motif-positive CXC chemokines and their receptor CXCR2 in monkey hippocampus after ischemia-reperfusion
Boryana K Popivanova et al. Brain Res. 2003.
Abstract
ELR(+) CXC chemokines including IL-8 are known to be involved in the ischemia-reperfusion injuries in various organs including rodent brain. However, the roles of these chemokines during the ischemia-reperfusion injuries of the primate brain still remain unknown. Here, we studied expressions of CXC chemokines and their receptor CXCR2 in monkey hippocampus known to develop total CA1 neuronal loss on day 5 after 20-min ischemia and reperfusion. ELR(+) chemokines and their receptor CXCR2 were not detected in the hippocampus of non-ischemic monkeys. On the contrary, at 30-60 min after the start of reperfusion, CD68-positive microglial cells increased significantly in the hippocampal CA1 sector, but there was negligible infiltration of neutrophils. These microglial cells expressed simultaneously growth regulated oncogene (Gro)-alpha and other ELR(+) CXC chemokines. Moreover, CD68-positive microglial cells also expressed the receptor for ELR(+) CXC chemokines. On day 4, capillary endothelial cells were significantly increased in the CA1 sector. Considering that ELR(+) CXC chemokines have potent angiogenic activities, the coordinate expression of ELR(+) CXC chemokines and their receptor CXCR2 in microglial cells may be related not only to the ischemic brain injuries but also to the microglial and capillary proliferation in the monkey hippocampus.
Similar articles
- The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, Xue YY, Buechi L, Walz A, Richmond A, Strieter RM. Addison CL, et al. J Immunol. 2000 Nov 1;165(9):5269-77. doi: 10.4049/jimmunol.165.9.5269. J Immunol. 2000. PMID: 11046061 - ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
Bizzarri C, Beccari AR, Bertini R, Cavicchia MR, Giorgini S, Allegretti M. Bizzarri C, et al. Pharmacol Ther. 2006 Oct;112(1):139-49. doi: 10.1016/j.pharmthera.2006.04.002. Epub 2006 May 23. Pharmacol Ther. 2006. PMID: 16720046 Review. - CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury.
Belperio JA, Keane MP, Burdick MD, Gomperts BN, Xue YY, Hong K, Mestas J, Zisman D, Ardehali A, Saggar R, Lynch JP 3rd, Ross DJ, Strieter RM. Belperio JA, et al. J Immunol. 2005 Nov 15;175(10):6931-9. doi: 10.4049/jimmunol.175.10.6931. J Immunol. 2005. PMID: 16272353 - Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.
Keane MP, Belperio JA, Xue YY, Burdick MD, Strieter RM. Keane MP, et al. J Immunol. 2004 Mar 1;172(5):2853-60. doi: 10.4049/jimmunol.172.5.2853. J Immunol. 2004. PMID: 14978086 - The role of CXC chemokines and their receptors in cancer.
Vandercappellen J, Van Damme J, Struyf S. Vandercappellen J, et al. Cancer Lett. 2008 Aug 28;267(2):226-44. doi: 10.1016/j.canlet.2008.04.050. Epub 2008 Jun 24. Cancer Lett. 2008. PMID: 18579287 Review.
Cited by
- Inflammation and Elevated Osteopontin in Plasma and CSF in Cerebral Malaria Compared to _Plasmodium_-Negative Neurological Infections.
Stins MF, Mtaja A, Mulendele E, Mwimbe D, Pinilla-Monsalve GD, Mutengo M, Pardo CA, Chipeta J. Stins MF, et al. Int J Mol Sci. 2024 Sep 5;25(17):9620. doi: 10.3390/ijms25179620. Int J Mol Sci. 2024. PMID: 39273566 Free PMC article. - CXCR2 Is Deregulated in ALS Spinal Cord and Its Activation Triggers Apoptosis in Motor Neuron-Like Cells Overexpressing hSOD1-G93A.
La Cognata V, D'Amico AG, Maugeri G, Morello G, Guarnaccia M, Magrì B, Aronica E, D'Agata V, Cavallaro S. La Cognata V, et al. Cells. 2023 Jul 9;12(14):1813. doi: 10.3390/cells12141813. Cells. 2023. PMID: 37508478 Free PMC article. - Construction of a lncRNA-associated competing endogenous RNA regulatory network after traumatic brain injury in mouse.
Wang S, Sun Y, Hu S, Lou C, Pan YB. Wang S, et al. Mol Brain. 2022 May 2;15(1):40. doi: 10.1186/s13041-022-00925-8. Mol Brain. 2022. PMID: 35501920 Free PMC article. - Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury.
Piotrowska A, Rojewska E, Pawlik K, Kreiner G, Ciechanowska A, Makuch W, Nalepa I, Mika J. Piotrowska A, et al. Front Immunol. 2019 Sep 26;10:2198. doi: 10.3389/fimmu.2019.02198. eCollection 2019. Front Immunol. 2019. PMID: 31616413 Free PMC article. - Crosstalk between NFκB-dependent astrocytic CXCL1 and neuron CXCR2 plays a role in descending pain facilitation.
Ni H, Wang Y, An K, Liu Q, Xu L, Zhu C, Deng H, He Q, Wang T, Xu M, Zheng Y, Huang B, Fang J, Yao M. Ni H, et al. J Neuroinflammation. 2019 Jan 3;16(1):1. doi: 10.1186/s12974-018-1391-2. J Neuroinflammation. 2019. PMID: 30606213 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous